查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571627

中风治疗市场规模、份额和趋势分析报告：按类型、药物类别、分销管道、地区和细分市场预测，2024-2030

Cerebral Infarction Treatment Market Size, Share & Trends Analysis Report By Type (Chemotherapy), By Drug Class (Oral), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

中风治疗市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球中风治疗市场规模预计将达到205亿美元，复合年增长率为7.3%。

由于世界人口老化导致缺血性中风盛行率不断上升，以及高血压和糖尿病等与生活方式相关的危险因子增加，是推动中风治疗市场扩大的关键因素。

根据美国国家医学图书馆2023年3月发表的研究，每年出血性中风占所有中风的10.0%至20.0%。不同地区的发生率差异很大，美国、英国和澳洲为 8.0% 至 15.0%，日本和韩国为 18.0% 至 24.0%。低收入和中等收入国家以及亚洲人群中出血性中风的发生率明显较高。此外，男性中风的发生率较高，并且随着年龄的增长而增加，而全球出血性中风的负担正在增加，特别是在非洲和亚洲国家。儘管有效的高血压管理已被证明可以降低脑出血（ICH）的发生率，但死亡率仍令人担忧，高所得国家的死亡率为25.0% 至30.0%，低收入地区为30% 至48% 。

技术进步显着改善了中风的治疗状况。组织胞浆素原原激活剂 (tPA) 等溶栓疗法的创新和机械血栓切除装置的开发显着改善了患者的治疗效果。此外，人工智慧（AI）融入诊断和治疗过程正在彻底改变中风治疗。人工智慧主导的演算法现在在预测中风风险和客製化治疗策略方面发挥关键作用，有助于个人化治疗并提高整体效果。这些进步不仅提高了治疗精度，而且有助于先进治疗方法的广泛采用。这些技术进步，加上研发投资的增加，预计将推动中风治疗市场的显着成长。

中风治疗市场报告亮点

  • 2023年，由于其盛行率高、技术进步以及早期疗育意识增强，缺血性脑中风领域占最大份额，达78.6%。
  • 组织胞浆素原激活剂（tPA）细分市场由于其经过验证的功效、广泛使用以及在缺血性中风治疗中的重要作用，在 2023 年占据了最大的收益占有率，达到 39.7%。
  • 2023年，医院药局部门在中风治疗市场占据主导地位，占了63.6%的巨大收益占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章中风治疗市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 中风治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章中风治疗市场：依治疗方法估算与趋势分析

  • 全球中风治疗市场仪表板：依治疗分类
  • 全球中风治疗市场波动分析：依治疗方式
  • 全球中风治疗市场收益：依治疗分类
  • 缺血性中风
  • 出血性中风

第五章中风治疗市场：依药物类别估算与趋势分析

  • 全球中风治疗市场仪表板：依药物类别
  • 全球中风治疗市场波动分析：依药物类别
  • 收益：按药物类别
  • 组织胞浆素原原激活剂
  • 抗凝血物
  • 抗血小板药
  • 抗凝血物
  • 其他的

第六章中风治疗市场：按通路估计和趋势分析

  • 全球中风治疗市场仪表板：按分销管道
  • 全球中风治疗市场波动分析：按分销管道
  • 收益：按分销管道划分
  • 医院药房
  • 零售药房
  • 其他的

第七章中风治疗市场：依地区估算及趋势分析

  • 仪表板：依地区
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • Key company market share analysis, 2023
    • Amgen Inc.
    • Pfizer Inc.
    • Novartis AG
    • Amneal Pharmaceuticals LLC
    • Sanofi
    • Abbott Laboratories
    • Johnson &Johnson
    • Bristol-Myers Squibb
Product Code: GVR-4-68040-450-8

Cerebral Infarction Treatment Market Growth & Trends:

The global cerebral infarction treatment market size is expected to reach USD 20.5 billion by 2030 and is projected to grow at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. The growing prevalence of ischemic strokes, driven by an aging global population and increasing rates of lifestyle-related risk factors such as hypertension and diabetes, is a key factor in the expansion of the cerebral infarction treatment market.

According to a study published by the National Library of Medicine in March 2023, hemorrhagic stroke accounts for 10.0% to 20.0% of all strokes annually. The incidence varies significantly by region, with 8.0%-15.0% in the U.S., the UK, and Australia, and 18.0% to 24.0% in Japan and Korea. The rate of hemorrhagic stroke is notably higher in low- and middle-income countries, and among Asians. Furthermore, while stroke incidence is higher in men and increases with age, the global burden of hemorrhagic stroke is rising, particularly in African and Asian countries. Effective management of hypertension has been shown to reduce the incidence of intracerebral hemorrhage (ICH), though the fatality rate remains a concern, ranging from 25.0% to 30.0% in high-income countries and 30% to 48% in lower-income regions, highlighting disparities in critical care efficacy.

Technological advancements are significantly enhancing the treatment landscape for cerebral infarction. Innovations in thrombolytic therapies, such as tissue plasminogen activators (tPA), and development of mechanical thrombectomy devices have markedly improved patient outcomes. Moreover, the integration of artificial intelligence (AI) into diagnostic and treatment processes is revolutionizing stroke care. AI-driven algorithms now play a crucial role in predicting stroke risk and tailoring treatment strategies, which helps in personalizing care and improving overall efficacy. These advancements are not only improving the precision of treatments but also contributing to the broader adoption of advanced therapeutic options. Combined with increased investment in research and development, these technological strides are expected to drive significant growth in the cerebral infarction treatment market.

Cerebral Infarction Treatment Market Report Highlights:

  • In 2023, the ischemic stroke segment held the largest share of 78.6% due to its high prevalence, technological advancements, and growing awareness of early intervention
  • The tissue plasminogen activators (tPA) segment secured the largest revenue share of 39.7% in 2023, driven by its proven efficacy, widespread use, and crucial role in treating ischemic strokes
  • In 2023, the hospital pharmacies segment dominated the cerebral infarction treatment market, capturing a substantial revenue share of 63.6%

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Drug Class
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Drug Class
    • 2.2.3. Distribution Channel
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cerebral Infarction Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence Cerebrovascular Diseases
      • 3.2.1.2. Advancements In Medical Technology
      • 3.2.1.3. Aging Global Population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Treatment and Devices
      • 3.2.2.2. Strict Regulatory Approvals
  • 3.3. Cerebral Infarction Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Cerebral Infarction Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Cerebral Infarction Treatment Market: Treatment Dashboard
  • 4.2. Global Cerebral Infarction Treatment Market: Treatment Movement Analysis
  • 4.3. Global Cerebral Infarction Treatment Market by Treatment , Revenue
  • 4.4. Ischemic Stroke
    • 4.4.1. Ischemic stroke market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Hemorrhagic stroke
    • 4.5.1. Hemorrhagic stroke market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cerebral Infarction Treatment Market: Drug Class Estimates & Trend Analysis

  • 5.1. Global Cerebral Infarction Treatment Market: Drug Class Dashboard
  • 5.2. Global Cerebral Infarction Treatment Market: Drug Class Movement Analysis
  • 5.3. Global Cerebral Infarction Treatment Market Estimates and Forecasts, By Drug Class, Revenue (USD Million)
  • 5.4. Tissue Plasminogen Activators
    • 5.4.1. Tissue Plasminogen Activators market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Anticoagulants
    • 5.5.1. Anticoagulants market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Antiplatelets
    • 5.6.1. Antiplatelets market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Anticoagulants
    • 5.7.1. Anticoagulants market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cerebral Infarction Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Cerebral Infarction Treatment Market: Distribution Channel Dashboard
  • 6.2. Global Cerebral Infarction Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Cerebral Infarction Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cerebral Infarction Treatment Market: Regional Estimates & Trend Analysis by Treatment, Drug Class, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. Amgen Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Pfizer Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Novartis AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Amneal Pharmaceuticals LLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Sanofi
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Abbott Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Johnson & Johnson
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Bristol-Myers Squibb
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 North America Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 North America Cerebral Infarction Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 Canada Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 11 Canada Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Mexico Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Mexico Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Europe Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Germany Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Germany Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Germany Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 UK Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 UK Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 24 UK Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 France Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 France Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 27 France Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Italy Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Italy Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Italy Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Spain Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Spain Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Spain Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Denmark Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Sweden Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Sweden Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Norway Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Norway Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Norway Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 China Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 China Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 China Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 52 Japan Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 India Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55 India Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Australia Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 61 Australia Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Thailand Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Thailand Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Latin America Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Brazil Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Argentina Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 MEA Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 MEA Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 81 South Africa Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 UAE Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 87 UAE Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Cerebral Infarction Treatment Market: Market Outlook
  • Fig. 14 Cerebral Infarction Treatment Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Cerebral Infarction Treatment Market Driver Impact
  • Fig. 18 Cerebral Infarction Treatment Market Restraint Impact
  • Fig. 19 Cerebral Infarction Treatment Market Strategic Initiatives Analysis
  • Fig. 20 Cerebral Infarction Treatment Market: Treatment Movement Analysis
  • Fig. 21 Cerebral Infarction Treatment Market: Treatment Outlook and Key Takeaways
  • Fig. 22 Ischemic Stroke market estimates and forecast, 2018 - 2030
  • Fig. 23 Hemorrhagic Stroke market estimates and forecast, 2018 - 2030
  • Fig. 24 Cerebral Infarction Treatment Market: Drug Class Movement Analysis
  • Fig. 25 Cerebral Infarction Treatment Market: Drug Class Outlook and Key Takeaways
  • Fig. 26 Tissue Plasminogen Activators market estimates and forecast, 2018 - 2030
  • Fig. 27 Anticoagulants market estimates and forecast, 2018 - 2030
  • Fig. 28 Antiplatelets market estimates and forecast, 2018 - 2030
  • Fig. 29 Anticonvulsants market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Cerebral Infarction Treatment Market: Distribution Channel Movement Analysis
  • Fig. 32 Cerebral Infarction Treatment Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 33 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 35 Other market estimates and forecast, 2018 - 2030
  • Fig. 36 Global Cerebral Infarction Treatment Market: Regional Movement Analysis
  • Fig. 37 Global Cerebral Infarction Treatment Market: Regional Outlook and Key Takeaways
  • Fig. 38 Global Cerebral Infarction Treatment market share and leading players
  • Fig. 39 North America, by country
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 China key country dynamics
  • Fig. 66 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Japan key country dynamics
  • Fig. 68 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Market share of key market players - Cerebral Infarction Treatment market